NO20076056L - Fremgangsmater for rensing av FC region inneholdende proteiner - Google Patents

Fremgangsmater for rensing av FC region inneholdende proteiner

Info

Publication number: NO20076056L
Authority: NO; Norway
Prior art keywords: methods; polypeptides; purifying; protein; present application
Prior art date: 2005-06-17

Application number

NO20076056A

Other languages

English (en)

Norwegian (no)

Inventor

Ranganathan Godavarti

Timothy Iskra

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-17

Filing date

2007-11-26

Publication date

2008-01-11

2007-11-26 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-01-11 Publication of NO20076056L publication Critical patent/NO20076056L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO20076056A 2005-06-17 2007-11-26 Fremgangsmater for rensing av FC region inneholdende proteiner NO20076056L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US69182105P	2005-06-17	2005-06-17
PCT/US2006/023478 WO2006138553A2 (en)	2005-06-17	2006-06-16	Methods of purifying fc region containing proteins

Publications (1)

Publication Number	Publication Date
NO20076056L true NO20076056L (no)	2008-01-11

Family

ID=37433887

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20076056A NO20076056L (no)	2005-06-17	2007-11-26	Fremgangsmater for rensing av FC region inneholdende proteiner
NO20076082A NO20076082L (no)	2005-06-17	2007-11-26	Fremgangsmater for rensing av anti A beta antistoffer

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20076082A NO20076082L (no)	2005-06-17	2007-11-26	Fremgangsmater for rensing av anti A beta antistoffer

Country Status (25)

Country	Link
US (3)	US7820799B2 (zh)
EP (3)	EP1896504B1 (zh)
JP (2)	JP5150488B2 (zh)
KR (2)	KR101247836B1 (zh)
CN (3)	CN101213211A (zh)
AR (2)	AR053633A1 (zh)
AU (2)	AU2006261185B2 (zh)
BR (2)	BRPI0611599A2 (zh)
CA (2)	CA2611815A1 (zh)
CR (2)	CR9576A (zh)
EA (2)	EA201100177A1 (zh)
EC (1)	ECSP088086A (zh)
ES (2)	ES2402650T3 (zh)
IL (2)	IL187642A (zh)
MA (1)	MA29609B1 (zh)
MX (2)	MX2007015952A (zh)
MY (1)	MY144484A (zh)
NI (1)	NI200700329A (zh)
NO (2)	NO20076056L (zh)
NZ (1)	NZ565044A (zh)
RU (1)	RU2415865C2 (zh)
SG (1)	SG162806A1 (zh)
TW (2)	TW200740839A (zh)
WO (2)	WO2006138737A2 (zh)
ZA (2)	ZA200710330B (zh)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7964192B1 (en)	1997-12-02	2011-06-21	Janssen Alzheimer Immunotherapy	Prevention and treatment of amyloidgenic disease
TWI239847B (en) *	1997-12-02	2005-09-21	Elan Pharm Inc	N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7588766B1 (en)	2000-05-26	2009-09-15	Elan Pharma International Limited	Treatment of amyloidogenic disease
US20080050367A1 (en) *	1998-04-07	2008-02-28	Guriq Basi	Humanized antibodies that recognize beta amyloid peptide
US6761888B1 (en)	2000-05-26	2004-07-13	Neuralab Limited	Passive immunization treatment of Alzheimer's disease
US7790856B2 (en) *	1998-04-07	2010-09-07	Janssen Alzheimer Immunotherapy	Humanized antibodies that recognize beta amyloid peptide
US6787523B1 (en) *	1997-12-02	2004-09-07	Neuralab Limited	Prevention and treatment of amyloidogenic disease
US7700751B2 (en)	2000-12-06	2010-04-20	Janssen Alzheimer Immunotherapy	Humanized antibodies that recognize β-amyloid peptide
MY139983A (en) *	2002-03-12	2009-11-30	Janssen Alzheimer Immunotherap	Humanized antibodies that recognize beta amyloid peptide
DE10303974A1 (de)	2003-01-31	2004-08-05	Abbott Gmbh & Co. Kg	Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
JP2006516639A (ja) *	2003-02-01	2006-07-06	ニユーララブ・リミテツド	可溶性Ａ−βに対する抗体を生成させるための能動免疫
PE20050627A1 (es) *	2003-05-30	2005-08-10	Wyeth Corp	Anticuerpos humanizados que reconocen el peptido beta amiloideo
CN101027391A (zh) *	2004-10-05	2007-08-29	惠氏公司	用于改善重组蛋白质产生的方法和组合物
WO2006047340A2 (en) *	2004-10-22	2006-05-04	Amgen Inc.	Methods for refolding of recombinant antibodies
US8916165B2 (en)	2004-12-15	2014-12-23	Janssen Alzheimer Immunotherapy	Humanized Aβ antibodies for use in improving cognition
AR051528A1 (es)	2004-12-15	2007-01-17	Neuralab Ltd	Anticuerpos humanizados que reconocen el peptido beta amiloideo
GT200600031A (es) *	2005-01-28	2006-08-29		Formulacion anticuerpo anti a beta
EP1896504B1 (en) *	2005-06-17	2012-11-21	Wyeth LLC	Methods of purifying fc region containing antibodies
KR20140087058A (ko)	2005-11-30	2014-07-08	애브비 인코포레이티드	아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
AU2006319358B2 (en)	2005-11-30	2012-01-19	AbbVie Deutschland GmbH & Co. KG	Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
NZ568012A (en) *	2005-12-12	2012-07-27	Ac Immune Sa	A beta 1-42 specific monoclonal antibodies with therapeutic properties
WO2010044803A1 (en) *	2008-10-17	2010-04-22	Elan Pharma International Limited	Treatment of amyloidogenic diseases
US8784810B2 (en) *	2006-04-18	2014-07-22	Janssen Alzheimer Immunotherapy	Treatment of amyloidogenic diseases
PL2046833T3 (pl) *	2006-07-14	2014-01-31	Ac Immune Sa	Humanizowane przeciwciało przeciw amyloidowi beta
KR101770312B1 (ko) *	2006-08-28	2017-08-22	아레스 트레이딩 에스.에이.	Ｆｃ함유 단백질을 정제하는 방법
EP2061802A1 (en) *	2006-08-28	2009-05-27	Ares Trading S.A.	Process for the purification of fc-fusion proteins
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
CA2842964A1 (en)	2006-09-13	2008-03-20	Abbvie Inc.	Cell culture improvements
US8455626B2 (en)	2006-11-30	2013-06-04	Abbott Laboratories	Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) *	2007-02-27	2014-11-25	AbbVie Deutschland GmbH & Co. KG	Method for the treatment of amyloidoses
US8003097B2 (en) *	2007-04-18	2011-08-23	Janssen Alzheimer Immunotherapy	Treatment of cerebral amyloid angiopathy
CN101970000A (zh) *	2007-04-18	2011-02-09	杨森阿尔茨海默氏症免疫治疗公司	脑淀粉样血管病的预防和治疗
JP2010528583A (ja) *	2007-06-11	2010-08-26	エーシーイミューンソシエテアノニム	アミロイドβに対するヒト化抗体
WO2008156622A1 (en) *	2007-06-12	2008-12-24	Ac Immune S.A.	Humanized antibodies to amyloid beta
US8048420B2 (en) *	2007-06-12	2011-11-01	Ac Immune S.A.	Monoclonal antibody
US8613923B2 (en)	2007-06-12	2013-12-24	Ac Immune S.A.	Monoclonal antibody
DK2182983T3 (da)	2007-07-27	2014-07-14	Janssen Alzheimer Immunotherap	Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
US20100297012A1 (en) *	2007-10-05	2010-11-25	Andrea Pfeifer	Humanized antibody
RU2538709C2 (ru) *	2007-10-05	2015-01-10	Дженентек, Инк.	Гуманизированное антитело
AU2008311367B2 (en)	2007-10-05	2014-11-13	Ac Immune S.A.	Use of anti-amyloid beta antibody in ocular diseases
JO3076B1 (ar) *	2007-10-17	2017-03-15	Janssen Alzheimer Immunotherap	نظم العلاج المناعي المعتمد على حالة apoe
CN101903403B (zh)	2007-10-19	2016-03-16	西雅图基因公司	Cd19结合剂及其应用
PL2840090T3 (pl)	2007-10-30	2018-07-31	Genentech, Inc.	Oczyszczanie przeciwciał za pomocą chromatografii kationowymiennej
US20100233678A1 (en) *	2007-11-13	2010-09-16	Beadling Leslie C	Tunable affinity ligands for the separation and detection of target substances
KR101247374B1 (ko) *	2008-06-26	2013-03-26	한국생명공학연구원	면역글로불린 Ｇ의 Ｆｃ 부위에 선택적으로 결합하는 신규펩타이드 및 그의 제조방법
US8592555B2 (en)	2008-08-11	2013-11-26	Emd Millipore Corporation	Immunoglobulin-binding proteins with improved specificity
AU2009307728B2 (en) *	2008-10-20	2014-12-11	Abbvie Inc.	Antibodies that bind to IL-18 and methods of purifying the same
WO2010048192A2 (en)	2008-10-20	2010-04-29	Abbott Laboratories	Viral inactivation during purification of antibodies
RU2520838C2 (ru)	2008-10-20	2014-06-27	Эббви Инк	Выделение и очистка антител с использованием аффинной хроматографии на основе белка а
AU2009314311B2 (en)	2008-10-29	2013-01-10	Ablynx N.V.	Methods for purification of single domain antigen binding molecules
AR073997A1 (es)	2008-10-29	2010-12-15	Wyeth Corp	Formulaciones de moleculas de union a antigeno de dominio unico. metodo. kit
US9067981B1 (en)	2008-10-30	2015-06-30	Janssen Sciences Ireland Uc	Hybrid amyloid-beta antibodies
US9631008B2 (en)	2008-12-22	2017-04-25	Hoffmann-La Roche Inc.	Immunoglobulin purification
SG162687A1 (en)	2008-12-24	2010-07-29	Millipore Corp	Caustic stable chromatography ligands
US8268820B2 (en) *	2009-03-26	2012-09-18	Hoffmann-La Roche Inc.	2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
AU2010243551B2 (en)	2009-04-30	2015-03-26	Ablynx Nv	Method for the production of domain antibodies
US9428548B2 (en)	2009-09-01	2016-08-30	Genentech, Inc.	Enhanced protein purification through a modified protein A elution
KR101632312B1 (ko)	2009-11-03	2016-06-21	삼성전자주식회사	항체 불변 영역에 특이적으로 결합하는 융합 단백질, 그의 제조 방법 및 이를 이용한 항체 분리 방법
US9233906B2 (en) *	2009-12-31	2016-01-12	Group Novasep SAS	Purification of succinic acid from the fermentation broth containing ammonium succinate
WO2011107518A1 (de) *	2010-03-05	2011-09-09	Boehringer Ingelheim International Gmbh	Selektive anreicherung von antikörpern
ES2648264T3 (es) *	2010-03-10	2017-12-29	F. Hoffmann-La Roche Ag	Procedimiento para la purificación de soluciones de inmunoglobulinas
CA2796339C (en)	2010-04-15	2020-03-31	Abbott Laboratories	Amyloid-beta binding proteins
CA2806909C (en)	2010-07-30	2019-12-17	Ac Immune S.A.	Safe and functional humanized antibodies
JP6147665B2 (ja)	2010-08-14	2017-06-14	アッヴィ・インコーポレイテッド	アミロイドベータ結合タンパク質
JP2014507649A (ja) *	2011-01-18	2014-03-27	バクスター・インターナショナル・インコーポレイテッド	ヒト血液中の抗βアミロイド抗体の測定
AU2012236486B2 (en) *	2011-03-29	2016-06-23	Glaxosmithkline Llc	Buffer system for protein purification
SG10201604554WA (en) *	2011-06-08	2016-07-28	Emd Millipore Corp	Chromatography matrices including novel staphylococcus aureus protein a based ligands
US10221210B2 (en) *	2011-07-20	2019-03-05	Zepteon, Incorporated	Polypeptide separation methods
BR112014009178A2 (pt) *	2011-10-19	2018-09-04	Roche Glycart Ag	métodos, uso, receptor e invenção
US20150239991A1 (en) *	2012-09-25	2015-08-27	Glenmark Pharmaceuticals S.A.	Purification of hetero-dimeric immunoglobulins
AR096713A1 (es)	2013-06-25	2016-01-27	Cadila Healthcare Ltd	Proceso de purificación para anticuerpos monoclonales
TW201509432A (zh)	2013-07-05	2015-03-16	Lab Francais Du Fractionnement	親和層析基質
IL320195A (en)	2013-09-13	2025-06-01	Genentech Inc	Methods and compositions containing purified recombinant polypeptides
MX2016015893A (es) *	2014-06-02	2017-03-20	Lab Francais Du Fractionnement	Produccion de fragmentos de fragmento cristalizable (fc).
JP6451118B2 (ja) *	2014-07-17	2019-01-16	東ソー株式会社	抗体の分離方法
AR101262A1 (es)	2014-07-26	2016-12-07	Regeneron Pharma	Plataforma de purificación para anticuerpos biespecíficos
US11566082B2 (en)	2014-11-17	2023-01-31	Cytiva Bioprocess R&D Ab	Mutated immunoglobulin-binding polypeptides
FR3038517B1 (fr)	2015-07-06	2020-02-28	Laboratoire Francais Du Fractionnement Et Des Biotechnologies	Utilisation de fragments fc modifies en immunotherapie
CN105175548B (zh) *	2015-08-13	2019-02-05	齐鲁制药有限公司	重组人血管内皮生长因子受体-抗体融合蛋白的纯化方法
CN107849122B (zh) *	2015-08-21	2022-01-25	豪夫迈·罗氏有限公司	用低电导率洗涤缓冲液进行亲和层析纯化
CA2992420A1 (en)	2015-08-21	2017-03-02	F. Hoffmann-La Roche Ag	Method for the reduction of host cell proteins in affinity chromatography
EP3337817B1 (en) *	2015-08-21	2021-09-15	F. Hoffmann-La Roche AG	Method for the reduction of host cell proteins in affinity chromatography
EP3344643B1 (en) *	2015-09-04	2025-07-02	Qiagen Sciences LLC	Methods for co-isolation of nucleic acids and proteins
GB201600161D0 (en) *	2016-01-05	2016-02-17	Bayer As	Isotope purification method
GB201600154D0 (en) *	2016-01-05	2016-02-17	Bayer As	Isotope preparation method
EA037960B1 (ru)	2016-04-27	2021-06-15	Эббви Инк.	Способ лечения эозинофильного эзофагита с применением антитела против il-13
JP7031934B2 (ja)	2016-05-11	2022-03-08	サイティバ・バイオプロセス・アールアンドディ・アクチボラグ	分離マトリックス
US10654887B2 (en)	2016-05-11	2020-05-19	Ge Healthcare Bio-Process R&D Ab	Separation matrix
US10703774B2 (en)	2016-09-30	2020-07-07	Ge Healthcare Bioprocess R&D Ab	Separation method
EP3455243B1 (en)	2016-05-11	2021-03-24	Cytiva BioProcess R&D AB	Separation matrix
US10889615B2 (en)	2016-05-11	2021-01-12	Cytiva Bioprocess R&D Ab	Mutated immunoglobulin-binding polypeptides
JP7106187B2 (ja)	2016-05-11	2022-07-26	サイティバ・バイオプロセス・アールアンドディ・アクチボラグ	分離マトリックスを保存する方法
US10730908B2 (en)	2016-05-11	2020-08-04	Ge Healthcare Bioprocess R&D Ab	Separation method
EP3455241B1 (en)	2016-05-11	2022-02-23	Cytiva BioProcess R&D AB	Method of cleaning and/or sanitizing a separation matrix
KR102579850B1 (ko) *	2016-07-22	2023-09-18	암젠 인크	Fc-함유 단백질의 정제 방법
US12448411B2 (en)	2016-09-30	2025-10-21	Cytiva Bioprocess R&D Ab	Separation method
CN106519029B (zh) *	2016-10-31	2020-03-17	山东泰邦生物制品有限公司	一种Aβ寡聚体抗体的制备工艺
WO2018170488A1 (en) *	2017-03-17	2018-09-20	Gilead Sciences, Inc.	Method of purifying an antibody
JP2018167260A (ja) *	2017-03-29	2018-11-01	三菱ケミカル株式会社	イオン交換体の保存方法、生理活性物質の精製装置及び生理活性物質の精製方法
JP7097433B2 (ja) *	2017-08-17	2022-07-07	ジャスト－エヴォテックバイオロジックス、インコーポレイテッド	宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法
US11447547B1 (en)	2017-12-13	2022-09-20	Amgen Inc.	Method of antigen-binding protein production
CN109929038B (zh) *	2017-12-15	2020-10-09	山东博安生物技术有限公司	Vegf捕获剂融合蛋白的纯化方法
CN108048477A (zh) *	2017-12-15	2018-05-18	南京理工大学	基于大肠杆菌表达系统的制备多肽的方法
CA3084059A1 (en)	2017-12-22	2019-06-27	Regeneron Pharmaceuticals, Inc.	System and method for characterizing drug product impurities
CN111902720B (zh)	2018-03-21	2025-02-07	沃特世科技公司	基于非抗体高亲和力的样品制备、吸附剂、装置和方法
CN112313344A (zh)	2018-04-24	2021-02-02	凯杰科技有限公司	从复杂样品中分离核酸并去除抑制剂
US20220314142A1 (en)	2019-07-01	2022-10-06	Pfizer Inc.	Improvements to wash solutions for protein a chromatography in an antibody purification process
CN112409477B (zh) *	2019-08-21	2022-11-08	广东菲鹏生物有限公司	IgM纯化方法
CN110724204B (zh) *	2019-11-18	2021-10-22	广东菲鹏制药股份有限公司	Fc融合蛋白的纯化方法
CN113968909A (zh) *	2020-07-22	2022-01-25	信达生物制药(苏州)有限公司	一种双特异性抗体的纯化方法
CN116348487A (zh)	2020-07-23	2023-06-27	欧萨尔普罗席纳有限公司	抗淀粉样β抗体
TW202504919A (zh)	2023-05-30	2025-02-01	美商派拉岡醫療公司	α4β7整合素抗體組合物及使用方法

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
JPS6147500A (ja)	1984-08-15	1986-03-07	Res Dev Corp Of Japan	キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en)	1984-08-27	1987-11-25	The Board Of Trustees Of The Leland Stanford Junior University	Chimeric receptors by dna splicing and expression
GB8422238D0 (en)	1984-09-03	1984-10-10	Neuberger M S	Chimeric proteins
JPS61134325A (ja)	1984-12-04	1986-06-21	Teijin Ltd	ハイブリツド抗体遺伝子の発現方法
US4676980A (en)	1985-09-23	1987-06-30	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Target specific cross-linked heteroantibodies
EP0247091B1 (en)	1985-11-01	1993-09-29	Xoma Corporation	Modular assembly of antibody genes, antibodies prepared thereby and use
US5225539A (en)	1986-03-27	1993-07-06	Medical Research Council	Recombinant altered antibodies and methods of making altered antibodies
US4801687A (en) *	1986-10-27	1989-01-31	Bioprobe International, Inc.	Monoclonal antibody purification process using protein A
US4851341A (en) *	1986-12-19	1989-07-25	Immunex Corporation	Immunoaffinity purification system
US5336603A (en) *	1987-10-02	1994-08-09	Genentech, Inc.	CD4 adheson variants
US5223409A (en) *	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
AU4308689A (en)	1988-09-02	1990-04-02	Protein Engineering Corporation	Generation and selection of recombinant varied binding proteins
US5225538A (en) *	1989-02-23	1993-07-06	Genentech, Inc.	Lymphocyte homing receptor/immunoglobulin fusion proteins
US5116964A (en)	1989-02-23	1992-05-26	Genentech, Inc.	Hybrid immunoglobulins
DK0463151T3 (da) *	1990-01-12	1996-07-01	Cell Genesys Inc	Frembringelse af xenogene antistoffer
US6150584A (en)	1990-01-12	2000-11-21	Abgenix, Inc.	Human antibodies derived from immunized xenomice
US5427908A (en)	1990-05-01	1995-06-27	Affymax Technologies N.V.	Recombinant library screening methods
EP0585287B1 (en)	1990-07-10	1999-10-13	Cambridge Antibody Technology Limited	Methods for producing members of specific binding pairs
GB9015198D0 (en)	1990-07-10	1990-08-29	Brien Caroline J O	Binding substance
US5770429A (en)	1990-08-29	1998-06-23	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
US5112952A (en) *	1990-09-28	1992-05-12	Pierce Chemical Company	Composition and method for isolation and purification of Immunoglobulin M
DE69129154T2 (de)	1990-12-03	1998-08-20	Genentech, Inc., South San Francisco, Calif.	Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
ES2330052T3 (es)	1991-03-01	2009-12-03	Dyax Corporation	Proteina quimerica que comprende micro-proteinas que tienen dos o mas puentes disulfuro y relaizaciones de las mismas.
ATE414768T1 (de)	1991-04-10	2008-12-15	Scripps Research Inst	Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de)	1991-07-08	1993-11-11	Deutsches Krebsforsch	Phagemid zum Screenen von Antikörpern
WO1993008829A1 (en)	1991-11-04	1993-05-13	The Regents Of The University Of California	Compositions that mediate killing of hiv-infected cells
US5786180A (en) *	1995-02-14	1998-07-28	Bayer Corporation	Monoclonal antibody 369.2B specific for β A4 peptide
ES2293661T3 (es) *	1996-11-27	2008-03-16	Genentech, Inc.	Purificacion por afinidad de polipeptido en una matriz de proteinas a.
JP2002514919A (ja) *	1997-04-04	2002-05-21	バイオサイトダイアグノスティックス，インコーポレイテッド	多価ライブラリーおよびポリクローナルライブラリー
US6750324B1 (en)	1997-12-02	2004-06-15	Neuralab Limited	Humanized and chimeric N-terminal amyloid beta-antibodies
US6787523B1 (en) *	1997-12-02	2004-09-07	Neuralab Limited	Prevention and treatment of amyloidogenic disease
US6710226B1 (en)	1997-12-02	2004-03-23	Neuralab Limited	Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
TWI239847B (en) *	1997-12-02	2005-09-21	Elan Pharm Inc	N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7588766B1 (en)	2000-05-26	2009-09-15	Elan Pharma International Limited	Treatment of amyloidogenic disease
US6743427B1 (en)	1997-12-02	2004-06-01	Neuralab Limited	Prevention and treatment of amyloidogenic disease
US6913745B1 (en) *	1997-12-02	2005-07-05	Neuralab Limited	Passive immunization of Alzheimer's disease
US7964192B1 (en) *	1997-12-02	2011-06-21	Janssen Alzheimer Immunotherapy	Prevention and treatment of amyloidgenic disease
US20080050367A1 (en)	1998-04-07	2008-02-28	Guriq Basi	Humanized antibodies that recognize beta amyloid peptide
US6761888B1 (en) *	2000-05-26	2004-07-13	Neuralab Limited	Passive immunization treatment of Alzheimer's disease
US7790856B2 (en) *	1998-04-07	2010-09-07	Janssen Alzheimer Immunotherapy	Humanized antibodies that recognize beta amyloid peptide
US7179892B2 (en)	2000-12-06	2007-02-20	Neuralab Limited	Humanized antibodies that recognize beta amyloid peptide
US20050059802A1 (en)	1998-04-07	2005-03-17	Neuralab Ltd	Prevention and treatment of amyloidogenic disease
US6787637B1 (en)	1999-05-28	2004-09-07	Neuralab Limited	N-Terminal amyloid-β antibodies
DZ3295A1 (fr)	2000-02-24	2001-08-30		Anticorps humanises sequestrant un peptide amyloide .beta.
TWI255272B (en)	2000-12-06	2006-05-21	Guriq Basi	Humanized antibodies that recognize beta amyloid peptide
US7700751B2 (en)	2000-12-06	2010-04-20	Janssen Alzheimer Immunotherapy	Humanized antibodies that recognize β-amyloid peptide
ATE420114T1 (de)	2001-04-30	2009-01-15	Lilly Co Eli	Humanisierte antikörper die das beta-amyloid peptid erkennen& x9;
ATE409047T1 (de)	2001-04-30	2008-10-15	Lilly Co Eli	Humanisierte antikörper
EP1519740A4 (en)	2001-08-17	2005-11-09	Lilly Co Eli	FASTER IMPROVEMENT OF COGNITION IN DISEASES ASSOCIATED WITH A-BETA
JP2005503789A (ja)	2001-08-17	2005-02-10	イーライ・リリー・アンド・カンパニー	抗Ａβ抗体
WO2003066662A2 (en) *	2002-02-05	2003-08-14	Genentech, Inc.	Protein purification
AR038568A1 (es)	2002-02-20	2005-01-19	Hoffmann La Roche	Anticuerpos anti-a beta y su uso
MY139983A (en)	2002-03-12	2009-11-30	Janssen Alzheimer Immunotherap	Humanized antibodies that recognize beta amyloid peptide
JP2006516639A (ja) *	2003-02-01	2006-07-06	ニユーララブ・リミテツド	可溶性Ａ−βに対する抗体を生成させるための能動免疫
US20040229330A1 (en) *	2003-02-27	2004-11-18	Bayer Pharmaceuticals Corporation	Integrated method for capture and purification of tagged proteins
PT1601697E (pt)	2003-02-28	2007-09-04	Lonza Biologics Plc	Purificação de anticorpos através de proteína a e cromatografia de troca iónica.
GB0304576D0 (en)	2003-02-28	2003-04-02	Lonza Biologics Plc	Protein a chromatography
PE20050627A1 (es)	2003-05-30	2005-08-10	Wyeth Corp	Anticuerpos humanizados que reconocen el peptido beta amiloideo
WO2005044856A2 (en) *	2003-10-27	2005-05-19	Wyeth	Removal of high molecular weight aggregates using hydroxyapatite chromatography
BRPI0417689A8 (pt) *	2003-12-17	2017-04-25	Elan Pharm Inc	Método para conjugar um imonógeno de peptídeo, composição, conjugado, composição imunogênica, método para induzir uma resposta imune em um indivíduo mamífero, e, uso do conjugado
DK1701968T3 (da) *	2003-12-17	2015-06-22	Wyeth Llc	Immunogene peptid-bærer-konjugater og fremgangsmåder til deres fremstilling
US20050249723A1 (en) *	2003-12-22	2005-11-10	Xencor, Inc.	Fc polypeptides with novel Fc ligand binding sites
EP1767217A1 (en)	2004-07-14	2007-03-28	Astellas Pharma Inc.	Agent for promoting the recovery from dysfunction after the onset of central neurological disease
CN101027391A (zh)	2004-10-05	2007-08-29	惠氏公司	用于改善重组蛋白质产生的方法和组合物
AR051800A1 (es)	2004-12-15	2007-02-07	Wyeth Corp	Anticuerpos a beta usados en mejorar la cognicion
AR051528A1 (es)	2004-12-15	2007-01-17	Neuralab Ltd	Anticuerpos humanizados que reconocen el peptido beta amiloideo
US8916165B2 (en) *	2004-12-15	2014-12-23	Janssen Alzheimer Immunotherapy	Humanized Aβ antibodies for use in improving cognition
CN101111264A (zh)	2005-01-28	2008-01-23	惠氏公司	稳定化的液体多肽制剂
GT200600031A (es)	2005-01-28	2006-08-29		Formulacion anticuerpo anti a beta
EP1896504B1 (en)	2005-06-17	2012-11-21	Wyeth LLC	Methods of purifying fc region containing antibodies
CN101970000A (zh) *	2007-04-18	2011-02-09	杨森阿尔茨海默氏症免疫治疗公司	脑淀粉样血管病的预防和治疗
US8003097B2 (en)	2007-04-18	2011-08-23	Janssen Alzheimer Immunotherapy	Treatment of cerebral amyloid angiopathy
DK2182983T3 (da)	2007-07-27	2014-07-14	Janssen Alzheimer Immunotherap	Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
JO3076B1 (ar) *	2007-10-17	2017-03-15	Janssen Alzheimer Immunotherap	نظم العلاج المناعي المعتمد على حالة apoe
IT1395574B1 (it)	2009-09-14	2012-10-16	Guala Dispensing Spa	Dispositivo di erogazione

2006
- 2006-06-16 EP EP06784989A patent/EP1896504B1/en active Active
- 2006-06-16 KR KR1020087000127A patent/KR101247836B1/ko not_active Expired - Fee Related
- 2006-06-16 US US11/455,203 patent/US7820799B2/en active Active
- 2006-06-16 KR KR1020077030436A patent/KR101307614B1/ko active Active
- 2006-06-16 EA EA201100177A patent/EA201100177A1/ru unknown
- 2006-06-16 JP JP2008517138A patent/JP5150488B2/ja active Active
- 2006-06-16 CN CNA200680021590XA patent/CN101213211A/zh active Pending
- 2006-06-16 MY MYPI20062873A patent/MY144484A/en unknown
- 2006-06-16 CN CN201510211982.3A patent/CN104926938B/zh active Active
- 2006-06-16 RU RU2007143162/10A patent/RU2415865C2/ru active
- 2006-06-16 MX MX2007015952A patent/MX2007015952A/es active IP Right Grant
- 2006-06-16 ES ES06785208T patent/ES2402650T3/es active Active
- 2006-06-16 CA CA002611815A patent/CA2611815A1/en not_active Abandoned
- 2006-06-16 EP EP06785208A patent/EP1896506B1/en active Active
- 2006-06-16 EA EA200800083A patent/EA015148B1/ru not_active IP Right Cessation
- 2006-06-16 MX MX2007015051A patent/MX2007015051A/es active IP Right Grant
- 2006-06-16 WO PCT/US2006/024026 patent/WO2006138737A2/en not_active Ceased
- 2006-06-16 BR BRPI0611599-3A patent/BRPI0611599A2/pt not_active IP Right Cessation
- 2006-06-16 BR BRPI0611600A patent/BRPI0611600B8/pt active IP Right Grant
- 2006-06-16 TW TW095121657A patent/TW200740839A/zh unknown
- 2006-06-16 AR ARP060102573A patent/AR053633A1/es unknown
- 2006-06-16 ZA ZA200710330A patent/ZA200710330B/xx unknown
- 2006-06-16 AU AU2006261185A patent/AU2006261185B2/en not_active Ceased
- 2006-06-16 EP EP11177582A patent/EP2388274A1/en not_active Withdrawn
- 2006-06-16 WO PCT/US2006/023478 patent/WO2006138553A2/en not_active Ceased
- 2006-06-16 SG SG201004275-2A patent/SG162806A1/en unknown
- 2006-06-16 NZ NZ565044A patent/NZ565044A/en not_active IP Right Cessation
- 2006-06-16 ZA ZA200710331A patent/ZA200710331B/xx unknown
- 2006-06-16 CN CNA2006800216391A patent/CN101365722A/zh active Pending
- 2006-06-16 CA CA2611816A patent/CA2611816C/en not_active Expired - Fee Related
- 2006-06-16 AR ARP060102572A patent/AR053632A1/es not_active Application Discontinuation
- 2006-06-16 ES ES06784989T patent/ES2405079T3/es active Active
- 2006-06-16 AU AU2006259298A patent/AU2006259298B2/en active Active
- 2006-06-16 TW TW095121622A patent/TWI372763B/zh not_active IP Right Cessation
- 2006-06-16 US US11/454,772 patent/US7825223B2/en not_active Expired - Fee Related
- 2006-06-16 JP JP2008517226A patent/JP5270337B2/ja not_active Expired - Fee Related
2007
- 2007-11-26 IL IL187642A patent/IL187642A/en active IP Right Grant
- 2007-11-26 NO NO20076056A patent/NO20076056L/no not_active Application Discontinuation
- 2007-11-26 NO NO20076082A patent/NO20076082L/no not_active Application Discontinuation
- 2007-11-27 IL IL187683A patent/IL187683A/en not_active IP Right Cessation
- 2007-12-07 CR CR9576A patent/CR9576A/es not_active Application Discontinuation
- 2007-12-07 CR CR9582A patent/CR9582A/es unknown
- 2007-12-17 NI NI200700329A patent/NI200700329A/es unknown
2008
- 2008-01-02 MA MA30537A patent/MA29609B1/fr unknown
- 2008-01-09 EC EC2008008086A patent/ECSP088086A/es unknown
2010
- 2010-10-12 US US12/903,053 patent/US8440799B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2006138553A3 (en)	2007-02-22
JP2008543881A (ja)	2008-12-04
BRPI0611599A2 (pt)	2011-02-22
ES2402650T3 (es)	2013-05-07
WO2006138737A8 (en)	2007-12-13
MA29609B1 (fr)	2008-07-01
JP2008543868A (ja)	2008-12-04
CA2611816A1 (en)	2006-12-28
KR20080023315A (ko)	2008-03-13
TWI372763B (en)	2012-09-21
US20070072307A1 (en)	2007-03-29
US7825223B2 (en)	2010-11-02
KR101307614B1 (ko)	2013-09-13
IL187642A0 (en)	2008-03-20
HK1117174A1 (zh)	2009-01-09
BRPI0611600A2 (pt)	2011-03-15
EP1896506B1 (en)	2013-01-02
TW200840821A (en)	2008-10-16
CA2611816C (en)	2014-05-27
AR053633A1 (es)	2007-05-09
AU2006259298B2 (en)	2012-06-14
WO2006138553A2 (en)	2006-12-28
BRPI0611600B1 (pt)	2021-04-13
MY144484A (en)	2011-09-30
RU2415865C2 (ru)	2011-04-10
AU2006261185B2 (en)	2012-02-16
NO20076082L (no)	2007-12-27
ECSP088086A (es)	2008-02-20
KR101247836B1 (ko)	2013-03-28
EP2388274A1 (en)	2011-11-23
MX2007015952A (es)	2008-03-07
WO2006138737A3 (en)	2007-03-22
CR9582A (es)	2008-05-05
TW200740839A (en)	2007-11-01
EP1896504A2 (en)	2008-03-12
AU2006259298A1 (en)	2006-12-28
US7820799B2 (en)	2010-10-26
CN104926938A (zh)	2015-09-23
NI200700329A (es)	2015-04-21
EP1896504B1 (en)	2012-11-21
MX2007015051A (es)	2008-01-18
NZ565044A (en)	2010-05-28
ZA200710330B (en)	2009-12-30
EA015148B1 (ru)	2011-06-30
EA200800083A1 (ru)	2008-06-30
BRPI0611600B8 (pt)	2021-05-25
JP5150488B2 (ja)	2013-02-20
IL187683A0 (en)	2008-08-07
EA201100177A1 (ru)	2011-06-30
EP1896506A2 (en)	2008-03-12
AU2006261185A1 (en)	2006-12-28
CN101365722A (zh)	2009-02-11
CN104926938B (zh)	2019-06-04
CA2611815A1 (en)	2006-12-28
IL187683A (en)	2015-02-26
RU2007143162A (ru)	2009-08-10
SG162806A1 (en)	2010-07-29
IL187642A (en)	2014-08-31
US20110160437A1 (en)	2011-06-30
CR9576A (es)	2008-03-06
AR053632A1 (es)	2007-05-09
KR20080059371A (ko)	2008-06-27
ZA200710331B (en)	2009-04-29
US20070082367A1 (en)	2007-04-12
US8440799B2 (en)	2013-05-14
JP5270337B2 (ja)	2013-08-21
WO2006138737A2 (en)	2006-12-28
ES2405079T3 (es)	2013-05-30
CN101213211A (zh)	2008-07-02

Publication	Publication Date	Title
NO20076056L (no)	2008-01-11	Fremgangsmater for rensing av FC region inneholdende proteiner
EA200970230A1 (ru)	2009-08-28	СПОСОБ ОЧИСТКИ Fc-СЛИТЫХ БЕЛКОВ
KR101569783B1 (ko)	2015-11-19	항체의 정제 방법
BRPI0820156B8 (pt)	2021-05-25	processo para purificação de uma biomolécula alvo
NZ587511A (en)	2012-08-31	Purified lymphotoxin-beta-receptor immunoglobulin fusion proteins and methods of their purification
DE602004026343D1 (de)	2010-05-12	Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen
ATE335006T1 (de)	2006-08-15	Verfahren zur aufreinigung von albumin
WO2004024866A3 (en)	2004-10-14	Protein purification
JP2007532477A5 (zh)	2012-03-22
WO2007133623A3 (en)	2008-03-13	Peptide diagnostic agent for lyme disease
RU2010105312A (ru)	2011-08-27	Хроматографические способы
WO2006110292A3 (en)	2007-04-05	Temperature-triggered immobilization and purification of antibodies
JP2011521653A5 (zh)	2011-11-10
NO20084672L (no)	2008-12-10	Binder for C-reaktiv protein
WO2008003707A3 (en)	2008-04-10	Minimized small peptides with high affinity for factor viii and factor viii-like proteins
RU2012133474A (ru)	2014-02-27	Очистка факторов свертывания крови
PL1960427T3 (pl)	2011-07-29	Multimeryczne polipeptydy receptora Fc
ATE496133T1 (de)	2011-02-15	Affinitätspolypeptid zur reinigung von rekombinanten proteinen
CN113166200A (zh)	2021-07-23	一种提高蛋白a层析法去除聚集体的方法
JP5089924B2 (ja)	2012-12-05	ＩｇＭ型抗体の精製方法、ＩｇＭ型抗体認識抗原の吸着材
Arakawa et al.	2025	Mini review for niche downstream processes
McCann et al.	2014	Use of mep HyperCel for polishing of human serum albumin
EP2129461A4 (en)	2013-07-03	Purification of immunoglobulins
WO2004092214A3 (en)	2004-11-18	Affinity purification system using troponin molecules as affinity ligands
EA200501217A1 (ru)	2007-02-27	Способ очистки белка семейства трансформирующих ростовых факторов

Legal Events

Date	Code	Title	Description
2011-01-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application